InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,281.60
(
0.35%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.28
(
0.95%
)
Bitcoin
61,442.77
(
1.04%
)
Post# of 18493
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ANESRI

Send PM Follow Ignore
Followers 10
Posts 997
Boards Moderated 0
Alias Born 01/17/2005

ANESRI

Re: None

Wednesday, 04/27/2011 7:14:18 PM

Wednesday, April 27, 2011 7:14:18 PM

Post# of 18493
HCV- New drugs - Telaprevir and Boceprevir maybe approved soon.

Standard therapy for HCV which is Pegylated alpha i nterferon (PEG) plus Ribavarin (RBV) will stay and the new drugs will be added to improve the Sustained Viral Response (SVR). The therapy still is atleast 24 weeks and costs approx $35,000.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AEMD News
More AEMD News
InvestorsHub NewsWire

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!